MAPT and Alzheimer disease: Clusterin (CLU/APOJ), an extracellular chaperone (particularly for tau [52]) and established AD risk gene [41], was significantly elevated in both eLEVs and eSEVs from AD patients, as well as in the brain parenchyma (P = 0.057).